AXN Aoxing Pharmaceutical Company New (delisted)

---

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE

SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 0-24185

Aoxing Pharmaceutical Company, Inc. (Exchange:  NYSE MKT)

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

1098 Foster City Blvd., Suite 106-810, Foster City, CA 94404                          Telephone: 646-367-1747

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

Pursuant to the requirements of the Securities Exchange Act of 1934, Aoxing Pharmaceutical Company, Inc. (Name of Issuer or Exchange) certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

_________________

¹   Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

SEC 1654 (03-06)      Persons  who respond  to   the collection  of   information contained in this form are not required to respond unless the form displays a   currently  valid  OMB  control number.

 

 

---